Literature DB >> 25952982

Efficacy of endoscopic mucosal resections for the management of small gastric adenomas with low-grade dysplasia.

Sung Min Park1, Joon Sung Kim, Jeong-Seon Ji, Hwang Choi, Bo-In Lee, Byung-Wook Kim.   

Abstract

OBJECTIVE: Gastric adenoma with low-grade dysplasia (LGD) can progress to gastric cancer; however, the optimal therapeutic modality for LGD has not been established. The aim of this study was to assess the efficacy, safety of and local recurrence following endoscopic mucosal resection (EMR) for LGD. Specifically, we compared EMR with circumferential precutting (EMR-P) and EMR using a dual-channel endoscope (EMR-D) for the treatment of LGD ≤2 cm.
MATERIALS AND METHODS: A total of 158 lesions from 147 patients with LGD treated by EMR were retrospectively analyzed. The en bloc resection rate, complete resection rate, procedure time, complication rate and local recurrence rate were compared between EMR-P and EMR-D.
RESULTS: The en bloc resection and complete resection rates of EMR were 91.1% and 90.5%, respectively. The bleeding and perforation rates were 1.3% and 1.3%, respectively. The local recurrence rate following EMR was 2.2%. The en bloc resection and complete resection rates did not differ between EMR-P and EMR-D (88.2% vs. 92.5%, p = not significant (NS); and 90.2% vs. 90.7%, p = NS, respectively). The procedure time was significantly longer for EMR-P compared with EMR-D (16 (5-141) vs. 7 (2-48) min, p < 0.001), and the complication rate was significantly higher for EMR-P (7.8% vs. 0.0%, p = 0.010). Local recurrence was not found in EMR-P, whereas the recurrence rate was 3.2% in EMR-D.
CONCLUSION: EMR is an effective method for the treatment of LGD ≤2 cm. Compared with EMR-P, EMR-D appears to be the more effective, technically simple and safer method.

Entities:  

Keywords:  adenoma; endoscopic surgical procedure; gastric neoplasm; low grade

Mesh:

Year:  2015        PMID: 25952982     DOI: 10.3109/00365521.2015.1045023

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  4 in total

1.  Reduction in the procedure time of hybrid endoscopic submucosal dissection for early gastric neoplasms: a multi-center retrospective propensity score-matched analysis.

Authors:  Mitsuru Esaki; Sho Suzuki; Toshiki Horii; Ryoji Ichijima; Shun Yamakawa; Hitoshi Shibuya; Chika Kusano; Hisatomo Ikehara; Takuji Gotoda
Journal:  Therap Adv Gastroenterol       Date:  2020-08-03       Impact factor: 4.409

2.  Risk Factors for Additional Surgery after Iatrogenic Perforations due to Endoscopic Submucosal Dissection.

Authors:  Gi Jun Kim; Sung Min Park; Joon Sung Kim; Jeong Seon Ji; Byung Wook Kim; Hwang Choi
Journal:  Gastroenterol Res Pract       Date:  2017-02-20       Impact factor: 2.260

3.  Predictive Model of Nonneoplastic Pathology after Endoscopic Resection of Gastric Epithelial Neoplasia.

Authors:  Tae-Geun Gweon; Byung-Wook Kim; Joon Sung Kim; Sung Min Park; Jeong Seon Ji; Bo In Lee
Journal:  Gut Liver       Date:  2020-03-15       Impact factor: 4.519

4.  Comparison of the procedure time differences between hybrid endoscopic submucosal dissection and conventional endoscopic submucosal dissection in patients with early gastric neoplasms: a study protocol for a multi-center randomized controlled trial (Hybrid-G trial).

Authors:  Mitsuru Esaki; Eikichi Ihara; Hiroyuki Fujii; Yorinobu Sumida; Kazuhiro Haraguchi; Shunsuke Takahashi; Tsutomu Iwasa; Kayoko Nakano; Masafumi Wada; Shinichi Somada; Yosuke Minoda; Haruei Ogino; Koshiro Tagawa; Yoshihiro Ogawa
Journal:  Trials       Date:  2022-02-21       Impact factor: 2.279

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.